Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Stock Short Interest Climbs 353.6%

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was the target of a significant growth in short interest in October. As of October 30th, there was short interest totaling 127 shares, a growth of 353.6% from the October 15th total of 28 shares. Based on an average trading volume of 2,797 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.

Innovator IBD Breakout Opportunities ETF Stock Up 0.5%

NYSEARCA BOUT opened at $39.24 on Friday. The firm has a market cap of $13.73 million, a price-to-earnings ratio of 17.56 and a beta of 1.04. The business has a 50-day moving average price of $42.06 and a 200-day moving average price of $43.40. Innovator IBD Breakout Opportunities ETF has a twelve month low of $35.05 and a twelve month high of $49.41.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.